Waardenburg syndrome is a rare congenital pigmentary disorder secondary to an abnormal distribution of neural crest-derived melanocytes during embryogenesis resulting in patchy areas of depigmentation. It is considered in the investigation of congenital sensorineural deafness.
Estimated prevalence of 1:42000 live births, with equal gender prevalence. Present in 2-5% of patients with congenital deafness 3.
The major manifestations of this syndrome include:
- pigmentation changes
- hair: premature graying, characteristic white forelock (poliosis)
- eyes: eyes with two different color irises (complete heterochromia irides), eyes with one iris having different colors (sectoral heterochromia irides), very pale or striking blue eyes
- skin: patchy hypopigmented lesions
- lateral displacement of the inner canthi of the eyes secondary to a prominent nasal root.
- varying degrees of congenital sensorineural deafness (occurs in one in five patients)
- neurologic manifestations
- peripheral neuropathy
- cerebellar ataxia
- intellectual disability
Rarer findings include:
- upper limb contractures (type III, Klein-Waardenburg syndrome)
- Hirschsprung's disease (type IV, Waardenburg-Shah syndrome)
Waardenburg syndrome is due to an abnormal distribution of neural crest-derived melanocytes during embryogenesis. There are at least four subtypes, with varying physical manifestations and genetic profiles.
It is usually inherited in an autosomal dominant pattern, involving PAX3 or MITF 3. However, some cases can have an autosomal recessive inheritance pattern (usually type IV, Waardenburg-Shah syndrome). A small percentage of cases have been reported in patients with no family history of the disease due to spontaneous mutations.
inner ear abnormalities, including aplasia of the posterior semicircular canal 6,7
Treatment and prognosis
- hearing loss:
- hearing augmentation
- cochlear implantation for severe hearing loss
History and etymology
PJ Waardenburg; Dutch ophthalmologist and geneticist who first described the condition in 1951 3.
- 1. Spritz RA. Piebaldism, Waardenburg syndrome, and related disorders of melanocyte development. Seminars in cutaneous medicine and surgery. 16 (1): 15-23. Pubmed
- 2. Dourmishev AL, Dourmishev LA, Schwartz RA, Janniger CK. Waardenburg syndrome. Int J Dermatol 1999; 38:656.
- 3. Read AP, Newton VE. Waardenburg syndrome. Journal of medical genetics. 34 (8): 656-65. Pubmed
- 4. Nayak CS, Isaacson G. Worldwide distribution of Waardenburg syndrome. The Annals of otology, rhinology, and laryngology. 112 (9 Pt 1): 817-20. doi:10.1177/000348940311200913 - Pubmed
- 5. Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg syndrome. Human mutation. 31 (4): 391-406. doi:10.1002/humu.21211 - Pubmed
- 6. Joshi VM, Navlekar SK, Kishore GR, Reddy KJ, Kumar EC. CT and MR imaging of the inner ear and brain in children with congenital sensorineural hearing loss. Radiographics : a review publication of the Radiological Society of North America, Inc. 32 (3): 683-98. doi:10.1148/rg.323115073 - Pubmed
- 7. Elmaleh-Bergès M, Baumann C, Noël-Pétroff N, Sekkal A, Couloigner V, Devriendt K, Wilson M, Marlin S, Sebag G, Pingault V. Spectrum of temporal bone abnormalities in patients with Waardenburg syndrome and SOX10 mutations. AJNR. American journal of neuroradiology. 34 (6): 1257-63. doi:10.3174/ajnr.A3367 - Pubmed